ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 616 - 630 of 5996 products
GenScript ProBio Forms Partnership to Expedite Novel Bio Immunitas Products
$5.00
Available
Asieris Collaborates with ReviR to Discover RNA Candidates for Genitourinary Tumors
$5.00
Available
China to Ban Export of Cutting-Edge Cell Therapy Technologies
$5.00
Available
Results from InnoCare’s BTK Lymphoma Trial Published in Hematology Journal
$5.00
Available
JiXing Buys Global Rights for Hypertension Candidate from PhaseBio
$5.00
Available
Structure Stages Expanded $161 Million IPO for Novel Small Molecules
$5.00
Available
Gracell Biotech to Start US Trial of Dual-Targeting CAR-T Therapy for Myeloma
$5.00
Available
AnHeart to Use Guardant’s Assays for NSCLC Trials of ROS1 Inhibitor
$5.00
Available
NeuShen and UMass Partner To Develop Gene Therapy for ALS
$5.00
Available
Nervtex AI Device Approved in China to Diagnose Parkinson’s
$5.00
Available
CS Pharma Acquires China Rights to Fibrosis Drug in $336 Million Agreement
$5.00
Available
CARsgen to Test Claudin18.2 mAb with Roche’s PD-L1 for Gastric Cancer
$5.00
Available
Help Therapeutics to Start Trial of Universal Cell Therapy for Heart Failure
$5.00
Available
HuidaGene’s CRISPR Therapy Approved to Start US Trial for Inherited Retinal Disease
$5.00
Available
Legend Reports CAR-T Meets PFS Endpoint as Second-line Therapy for MM
$5.00
Available